ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Capp Heads Roentgen Ray Society; Annual Lecture, Chair Honors Charles Spurr

June 22, 1990

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986

Bloch Pushes PDQ Promotion To Public, But NCAB Limits It to Physicians

February 17, 1984

Virus Program Report On Scientific Activities

August 15, 1975

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987

Virus Program Changes reviews Subcommittee Report Set Fro June

November 23, 1974